We are live on ! Find out more
RG

Redmile Group Portfolio holdings

AUM $1.51B
1-Year Est. Return 164.17%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$5.73B
AUM Growth
-$1.02B
Cap. Flow
-$157M
Cap. Flow %
-2.73%
Top 10 Hldgs %
44.42%
Holding
91
New
5
Increased
15
Reduced
36
Closed
16

Top Buys

Rank Stock Value
1
ABSI icon
Absci
ABSI
+$156M
2
IVVD icon
Invivyd
IVVD
+$121M
3
LIVN icon
LivaNova
LIVN
+$88.7M
4
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$44.8M
5
STVN icon
Stevanato
STVN
+$28M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$98.4M
2
ZY
Zymergen Inc. Common Stock
ZY
+$60.9M
3
SLQT icon
SelectQuote
SLQT
+$46.5M
4
CRL icon
Charles River Laboratories
CRL
+$40.1M
5
CI icon
Cigna
CI
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 93.97%
2 Consumer Staples 3.39%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARDX icon
76
Ardelyx
ARDX
$1.28B
– –
-3,714,100
Closed -$28.2M
AVIR icon
77
Atea Pharmaceuticals
AVIR
$390M
– –
-237,360
Closed -$5.1M
CI icon
78
Cigna
CI
$74.5B
– –
-159,727
Closed -$37.9M
CRL icon
79
Charles River Laboratories
CRL
$10.8B
– –
-108,374
Closed -$40.1M
DXCM icon
80
DexCom
DXCM
$29.6B
– –
-922,232
Closed -$98.4M
INNV icon
81
InnovAge Holding
INNV
$1.56B
– –
-843,578
Closed -$18M
QSI icon
82
Quantum-Si Incorporated
QSI
$179M
– –
-1,700,000
Closed -$20.8M
QTRX icon
83
Quanterix
QTRX
$182M
– –
-240,933
Closed -$14.1M
SLQT icon
84
SelectQuote
SLQT
$127M
– –
-2,411,957
Closed -$46.5M
STIM icon
85
Neuronetics
STIM
$113M
– –
-394,355
Closed -$6.32M
TMCI icon
86
Treace Medical Concepts
TMCI
$279M
– –
-323,765
Closed -$10.1M
ZNTL icon
87
Zentalis Pharmaceuticals
ZNTL
$364M
– –
-425,480
Closed -$22.6M
CTLT
88
DELISTED
CATALENT, INC.
CTLT
– –
-310,111
Closed -$33.5M
TLIS
89
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
– –
-24,257
Closed -$4.01M
ZY
90
DELISTED
Zymergen Inc. Common Stock
ZY
– –
-1,522,900
Closed -$60.9M
PPD
91
DELISTED
PPD, Inc. Common Stock
PPD
– –
-466,471
Closed -$21.5M
1 2 3
4

Similar funds

ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.52B AUM 18.08% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return

Redmile Group's Q3 2021 Portfolio in Review

As of Q3 2021, Redmile Group held 91 positions worth $5.73B, down 15% from $6.76B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Redmile Group's Q3 2021 filing shows 5 new, 15 increased, 36 reduced and 16 closed positions. Its largest new stake was Absci: 8,031,094 shares worth $93.4M. The largest sale was DexCom, an estimated $98.4M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier, followed by Consumer Staples and Financials.

  • Redmile Group's largest Q3 2021 buy was Absci: 8,031,094 shares worth $93.4M.
  • Redmile Group added most to LivaNova in Q3 2021, an estimated $88.7M increase.
  • Redmile Group's biggest Q3 2021 reduction was Seagen Inc. Common Stock, cutting an estimated $28.6M.
  • Redmile Group fully exited DexCom in Q3 2021, selling an estimated $98.4M.
  • Redmile Group's ten largest holdings make up 44% of its $5.73B portfolio in Q3 2021.
  • Redmile Group opened 5 new positions and closed 16 in Q3 2021.
  • Redmile Group's portfolio value fell 15% quarter-over-quarter to $5.73B.

Based on Redmile Group's 13F filing for Q3 2021, filed 15 Nov 2021.